News 20 May 2026

Etihad Orders 10 Boeing Jets, Raising Talk of Hard-to-Get 787 Slots

Stock Market Today: Live Updates 14.07.2026

LIVEMarkets rolling coverageStarted: July 14, 2026, 4:00 AM EDTUpdated: July 14, 2026, 9:18 AM EDT Coronado Global Resources Taps van der Merwe as CEO as Coal Prices Stay Soft July 14, 2026, 9:00 AM EDT. Coronado Global Resources (ASX:CRN) has picked Barrie van der Merwe as its next CEO, with the change taking effect August 1, 2026. He takes over from interim chief and founder Gerry Spindler, who stays on the board as a non-executive director. Van der Merwe, the current CFO with 30 years in mining, is expected to bring strong operational and financial focus. Coronado is dealing with
July 14, 2026
Esperion Shares Flat at $3.16 as Archimed Bid Nears Endgame
····

Esperion Shares Flat at $3.16 as Archimed Bid Nears Endgame

Esperion Therapeutics shares stayed flat at $3.13 late Wednesday, just under Archimed’s $3.16-a-share cash offer. Investors are looking at what’s left in the take-private deal and the open milestone risks. The stock moved in a tight range from $3.13 to $3.14, with volume topping 7 million shares. Esperion isn’t just a small-cap drug name trading on growth anymore. Now it’s more of a merger spread play, with shares moving on the gap between the deal price and where it trades. The spread’s slim, but still there.
May 20, 2026
ARGX Stock Watch: Argenx Up Ahead of Immunovant Trial Data
······

ARGX Stock Watch: Argenx Up Ahead of Immunovant Trial Data

argenx SE’s U.S. shares inched up Wednesday, trailing the biotech sector after Immunovant released rheumatoid-arthritis data that drew new focus to the same drug class as argenx’s VYVGART franchise. ARGX was trading at $803.67 near the end of the session, up 0.7%. The iShares Nasdaq Biotechnology ETF added 2.1% and SPDR S&P Biotech ETF climbed 3.8%. Shares of Immunovant soared 35.1%. Roivant Sciences, Immunovant’s parent, rose 14.6%, according to market data.
May 20, 2026
Why Revelation Biosciences Stock Jumped Today as Traders Eye Its Kidney-Drug Bet
····

Why Revelation Biosciences Stock Jumped Today as Traders Eye Its Kidney-Drug Bet

Revelation Biosciences shares were quoted at $1.09 after the U.S. market close on Wednesday, up $0.06, or 5.82%, giving the clinical-stage biotech a market value of about $4.1 million. The move beat a firmer Nasdaq session, with the broader index up about 1.55% late in the day. The gain was not a catch-up trade after a holiday. Nasdaq’s 2026 calendar lists Memorial Day on May 25 as the next U.S. market closure, leaving Wednesday as a regular trading session for REVB.
May 20, 2026
Ituran Shares Tick Higher Ahead of Results
····

Ituran Shares Tick Higher Ahead of Results

Ituran Location and Control Ltd. shares edged up 0.39% to $57.17 Wednesday on Nasdaq. Investors are waiting for the vehicle-telematics company’s first-quarter report next week. Around 77,164 shares changed hands. The company has a market cap near $1.14 billion. Shares finished below their 52-week high of $62.31. Ituran’s move is getting attention with its earnings report set for six days from now. The company is due to post Q1 2026 results on May 26 and will hold a management call for investors at 9 a.m. Eastern. Management will discuss results and take questions.
May 20, 2026
Fifth Era Stock Little Changed as Traders Watch $10 Billion Metals Deal
····

Fifth Era Stock Little Changed as Traders Watch $10 Billion Metals Deal

Fifth Era Acquisition Corp I was flat in quiet Nasdaq trade Wednesday, with shares near the cash amount investors could get if its merger deal with strategic metals firm Miotal falls apart. That’s what’s happening with the stock lately. FERA isn’t trading like a regular operating company. It’s moving more like a SPAC, or special purpose acquisition company. In other words, a shell from an IPO out to merge with a private firm.
May 20, 2026
CoinShares Shares Recover After $1 Billion Fund Exit Hits Nasdaq Debutant
····

CoinShares Shares Recover After $1 Billion Fund Exit Hits Nasdaq Debutant

CoinShares PLC shares bounced back Wednesday, recovering some ground after a steep drop. Investors looked at another round of outflows from crypto funds and the firm’s move to attract U.S. institutions following its Nasdaq debut. The stock rose 3.3% to $5.33 on the Nasdaq in afternoon trading. Session range was $5.17 to $5.405. About 172,000 shares changed hands by late afternoon, below volumes in bigger crypto-linked stocks. Bitcoin traded close to $77,354, with ether near $2,130.
May 20, 2026
Immutep Shares Drop as Investors Face Trial Setback, Lawsuit Date and Nasdaq Alert
····

Immutep Shares Drop as Investors Face Trial Setback, Lawsuit Date and Nasdaq Alert

Immutep Ltd’s Nasdaq ADRs dropped around 5% Wednesday afternoon, missing out on gains in the biotech sector. New investor-law firm notices added to investor focus on lawsuits over the failed lung-cancer trial. The ADRs last changed hands at $0.4778, off a low of $0.4606. The SPDR S&P Biotech ETF climbed about 3.5%. Immutep is under pressure as it deals with a stock price below $1 on Nasdaq, shareholder litigation notices and efforts to recover trust following the halt of its TACTI-004 Phase III trial in first-line non-small cell lung cancer in March. Nasdaq’s regular U.S. market hours are 9:30 a.m. to 4 p.m. Eastern, according to Nasdaq.
May 20, 2026
Krispy Kreme Stock Pops as DNUT’s Turnaround Faces Its Next Test
·····

Krispy Kreme Stock Pops as DNUT’s Turnaround Faces Its Next Test

Krispy Kreme shares rose 14 cents, or about 4.4%, to $3.35 in Wednesday afternoon trading, outpacing broader U.S. stock trackers as former partner McDonald’s traded little changed. The S&P 500 tracker SPY was up about 0.8%, while the Nasdaq-100 tracker QQQ gained about 1.3%. The move puts a familiar question back in front of investors: whether Krispy Kreme can turn brand heat into steadier cash generation. For DNUT, the flavor cycle is not the whole story. The balance sheet is.
May 20, 2026
Exelixis Up After Merck Pact Focuses Attention on Cancer Study
·····

Exelixis Up After Merck Pact Focuses Attention on Cancer Study

Exelixis shares climbed Wednesday after the company announced a new Merck partnership, putting its next cancer drug program further into late-stage trials. Shares traded 2.5% higher at $49.89 in the afternoon, putting the Alameda, California-based company’s market cap near $13.3 billion. Biotech stocks were strong, with the iShares Nasdaq Biotechnology ETF up 1.8% and the SPDR S&P Biotech ETF up 3.8%.
May 20, 2026
NEUP Stock Moves Higher as Traders Focus on Neuphoria’s Cash Runway
····

NEUP Stock Moves Higher as Traders Focus on Neuphoria’s Cash Runway

Neuphoria Therapeutics Inc. shares traded higher in midday action Wednesday. The move came as biotech stocks attracted buyers, although Neuphoria’s newest filing pointed to a focus on conserving cash and weighing options over any immediate drug revenue. The stock, which trades on Nasdaq, last changed hands at $5.00, up 23 cents. Shares opened at $4.71 and ranged from $4.77 to $5.00. Volume hit 33,745 shares on the latest trade—enough to stand out, though well below large-cap levels.
May 20, 2026
NervGen Stock Climbs with Trial Approaching, Cash Burn Still a Focus
····

NervGen Stock Climbs with Trial Approaching, Cash Burn Still a Focus

NervGen Pharma Corp. was up almost 4% to $3.70 in midday Nasdaq trade Wednesday, lifted by its latest quarterly update as the company preps for its late-stage RESTORE trial. Shares moved between $3.58 and $3.75 and about 59,940 shares were traded. NervGen is moving from lining up with regulators to actually starting work. The company said this week it’s got an agreement with the U.S. Food and Drug Administration on RESTORE, the registrational study of NVG-291 for chronic tetraplegia, where all four limbs are paralyzed. CEO Adam Rogers said NervGen is “firmly in execution mode.” Site activation has started, and the study is still on track to kick off in mid-2026.
May 20, 2026
Aurora Shares Bounce, but Traders Eye SEC Filing
····

Aurora Shares Bounce, but Traders Eye SEC Filing

Aurora Innovation Inc moved higher on Wednesday, up 19 cents to $7.13, bouncing after a two-day drop. Shares traded in a range from $6.795 to $7.19. Volume was around 9.6 million. Fresh insider-sale filings and the company’s driverless freight expansion remained in focus for investors. Aurora is seeing its valuation move away from that of a regular transport operator, trading more like an autonomous trucking play. Shares dropped 3.8% Monday and another 6.5% Tuesday. Aurora closed last Wednesday at $8.40, StockAnalysis data show.
May 20, 2026
Icahn Enterprises Stock Holds Steady as Investors Eye Dividend Decision
····

Icahn Enterprises Stock Holds Steady as Investors Eye Dividend Decision

Icahn Enterprises L.P. units traded slightly up at midday Wednesday while the broader U.S. market gained ground. Investors kept an eye on Carl Icahn’s holding company after its June payout and asset-value update. IEP last changed hands at $7.53, up 0.3%. The units moved in a range between $7.47 and $7.74. Troubled Icahn Enterprises’ $0.50 quarterly payout is still drawing eyes. Holders had just crossed the May 18 record date, with the distribution due around June 25. The company kept the option for unitholders—cash or more depositary units. If holders don’t pick in time, they’ll get more units by default.
May 20, 2026
Bogota Financial Shares Steady; Deposit Data Draws Attention
····

Bogota Financial Shares Steady; Deposit Data Draws Attention

Bogota Financial Corp. ticked up to $8.40 in light action on the Nasdaq Wednesday. Not much movement, but filings highlighting deposit outflows and more wholesale funding kept the spotlight on the New Jersey lender’s balance sheet. The market saw just 853 shares trade, leaving its value near $105.9 million. Trading happened during the standard U.S. equity session. Nasdaq’s main market runs from 9:30 a.m. to 4 p.m. Eastern. Memorial Day on May 25 will be the next scheduled U.S. equity market holiday.
May 20, 2026
Smithfield Foods Shares Flat Near $26
····

Smithfield Foods Shares Flat Near $26

Smithfield Foods traded near flat on Nasdaq Wednesday, the stock hovering at $26.10 in late morning, up about 0.1%. The market cap stood close to $10.3 billion. Volume was thin at around 313,000 shares. That’s still on the light side as investors continue to assess the company’s 2025 public comeback. Smithfield’s latest news wasn’t market-moving. The company announced more than $280,000 in Impact Grants to a dozen nonprofits, pitching its community efforts rather than results or forecasts. “Real needs and creating lasting positive change,” said Jim Monroe, vice president of corporate affairs.
May 20, 2026
Mesa Labs Shares Jump Ahead of Key Date
····

Mesa Labs Shares Jump Ahead of Key Date

Mesa Laboratories Inc. shares gained 2% to $101.78 late Wednesday morning. About 88,900 shares traded. The small-cap life-science tools company is up ahead of its year-end report next week. Shares moved between $98.52 and $102.52. Mesa will report its fiscal fourth quarter and full-year results on May 27, for the year that ended March 31. The release is set for around 6 a.m. Eastern time.
May 20, 2026
1 … 163 164 165 166 167 … 492